ACHV

Achieve Life Sciences (ACHV)

About Achieve Life Sciences (ACHV)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Details

Daily high

$5.35

Daily low

$4.74

Price at open

$4.81

52 Week High

$6.02

52 Week Low

$2.00

Market cap

491.7M

Dividend yield

0.00%

Volume

3,408

Avg. volume

1.8M

P/E ratio

-3.70

Achieve Life Sciences News